1 – 5 of 28
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
(
- Contribution to journal › Article
- 2015
-
Mark
The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.
(
- Contribution to journal › Article
- 2012
-
Mark
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
(
- Contribution to journal › Article
- 2010
-
Mark
Gastrin response to candidate messengers in intact conscious rats monitored by antrum microdialysis.
(
- Contribution to journal › Article